Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
38 questions in 9 reviews · HIV/AIDS
current versionsNo studies 38 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Doctor vs community health worker Outcomes2 · HIV infected patients on antiretroviral therapy. Task shifting from doctors to non‐doctors for initiation and maintenance of antiretroviral therapy (2014) · Cochrane | no estimate extracted | NR | No studies |
Hepatitis B vaccination vs placebo Hepatitis B Virus infection ‐ not measured · Persons with HIV infection Hepatitis B vaccination for reducing morbidity and mortality in persons with HIV infection (2014) · Cochrane | no estimate extracted | NR | No studies |
Hepatitis B vaccination vs placebo Hepatitis B virus morbidity ‐ not measured · Persons with HIV infection Hepatitis B vaccination for reducing morbidity and mortality in persons with HIV infection (2014) · Cochrane | no estimate extracted | NR | No studies |
Hepatitis B vaccination vs placebo Hepatitis B virus related mortality ‐ not measured · Persons with HIV infection Hepatitis B vaccination for reducing morbidity and mortality in persons with HIV infection (2014) · Cochrane | no estimate extracted | NR | No studies |
Hepatitis B vaccination vs placebo All cause mortality ‐ not measured · Persons with HIV infection Hepatitis B vaccination for reducing morbidity and mortality in persons with HIV infection (2014) · Cochrane | no estimate extracted | NR | No studies |
IMMEDIATE initiation of cART vs DEFERRED initiation of cART Patient or population: HIV‐positive, treatment‐naive children aged 24 to 59 months (2 to 5 years old)Settings: Thailand and CambodiaIntervention: IMMEDIATE initiation of cARTComparison: DEFERRED initiation of cART · HIV‐positive, treatment‐naive children aged one to 12 years old Optimal time for initiating antiretroviral therapy (ART) in HIV‐infected, treatment‐naive children aged 2 to… (2013) · Cochrane | no estimate extracted | NR | No studies |
HAART regimen + topical treatment vs HAART regimen alone Adverse effects of long‐term use of available topical agents · HIV‐infected adults (> 13 years of age, per CDC) with one or more painful intraoral aphthous ulcers Topical treatments for HIV‐related oral ulcers (2012) · Cochrane | No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6… | 0 studies | No studies |
Antiseptic mouthwash (e.g. chlorhexidine) vs Another topical agent or placebo Pain relief · HIV‐infected adults (> 13 years of age, per CDC) with one or more painful intraoral aphthous ulcers Topical treatments for HIV‐related oral ulcers (2012) · Cochrane | No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6… | 0 studies | No studies |
Topical thalidomide vs Another topical agent or placebo Pain relief · HIV‐infected adults (> 13 years of age, per CDC) with one or more painful intraoral aphthous ulcers Topical treatments for HIV‐related oral ulcers (2012) · Cochrane | No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6… | 0 studies | No studies |
Topical corticosteroids vs Another topical agent or placebo Duration to heal oral ulcerations after initiation of treatment · HIV‐infected adults (> 13 years of age, per CDC) with one or more painful intraoral aphthous ulcers Topical treatments for HIV‐related oral ulcers (2012) · Cochrane | No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6… | 0 studies | No studies |
Antiseptic mouthwash (e.g. chlorhexidine) vs Another topical agent or placebo Duration to heal oral ulcerations after initiation of treatment · HIV‐infected adults (> 13 years of age, per CDC) with one or more painful intraoral aphthous ulcers Topical treatments for HIV‐related oral ulcers (2012) · Cochrane | No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6… | 0 studies | No studies |
HAART regimen + topical treatment vs HAART regimen alone Healing of ulceration · HIV‐infected adults (> 13 years of age, per CDC) with one or more painful intraoral aphthous ulcers Topical treatments for HIV‐related oral ulcers (2012) · Cochrane | No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6… | 0 studies | No studies |
Topical thalidomide vs Another topical agent or placebo Incidence and recurrence after healing of ulcers · HIV‐infected adults (> 13 years of age, per CDC) with one or more painful intraoral aphthous ulcers Topical treatments for HIV‐related oral ulcers (2012) · Cochrane | No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6… | 0 studies | No studies |
Topical corticosteroids vs Another topical agent or placebo Healing of ulceration · HIV‐infected adults (> 13 years of age, per CDC) with one or more painful intraoral aphthous ulcers Topical treatments for HIV‐related oral ulcers (2012) · Cochrane | No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6… | 0 studies | No studies |
Antiseptic mouthwash (e.g. chlorhexidine) vs Another topical agent or placebo Healing of ulceration · HIV‐infected adults (> 13 years of age, per CDC) with one or more painful intraoral aphthous ulcers Topical treatments for HIV‐related oral ulcers (2012) · Cochrane | No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6… | 0 studies | No studies |
Topical corticosteroids vs Another topical agent or placebo Pain relief · HIV‐infected adults (> 13 years of age, per CDC) with one or more painful intraoral aphthous ulcers Topical treatments for HIV‐related oral ulcers (2012) · Cochrane | No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6… | 0 studies | No studies |
Antiseptic mouthwash (e.g. chlorhexidine) vs Another topical agent or placebo Incidence and recurrence after healing of ulcers · HIV‐infected adults (> 13 years of age, per CDC) with one or more painful intraoral aphthous ulcers Topical treatments for HIV‐related oral ulcers (2012) · Cochrane | No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6… | 0 studies | No studies |
Topical corticosteroids vs Another topical agent or placebo Adverse effects of long‐term use of available topical agents · HIV‐infected adults (> 13 years of age, per CDC) with one or more painful intraoral aphthous ulcers Topical treatments for HIV‐related oral ulcers (2012) · Cochrane | No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6… | 0 studies | No studies |
Topical corticosteroids vs Another topical agent or placebo Incidence and recurrence after healing of ulcers · HIV‐infected adults (> 13 years of age, per CDC) with one or more painful intraoral aphthous ulcers Topical treatments for HIV‐related oral ulcers (2012) · Cochrane | No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6… | 0 studies | No studies |
HAART regimen + topical treatment vs HAART regimen alone Duration to heal oral ulcerations after initiation of treatment · HIV‐infected adults (> 13 years of age, per CDC) with one or more painful intraoral aphthous ulcers Topical treatments for HIV‐related oral ulcers (2012) · Cochrane | No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6… | 0 studies | No studies |
Intervention NR CD4+ count · HIV infected adults who meet the WHO criteria for commencing antiretroviral treatment. Effectiveness and safety of first-line tenofovir + emtricitabine + efavirenz for patients with HIV (2012) · Cochrane | no estimate extracted | NR | No studies |
Motivational interviewing vs control Adherence ‐ not measured · patients with Improving outcomes in youth living with HIV Motivational interviewing for improving outcomes in youth living with HIV (2012) · Cochrane | no estimate extracted | NR | No studies |
Motivational interviewing vs control Mortality ‐ not measured · patients with Improving outcomes in youth living with HIV Motivational interviewing for improving outcomes in youth living with HIV (2012) · Cochrane | no estimate extracted | NR | No studies |
Motivational interviewing vs control Quality of life ‐ not measured · patients with Improving outcomes in youth living with HIV Motivational interviewing for improving outcomes in youth living with HIV (2012) · Cochrane | no estimate extracted | NR | No studies |
Topical thalidomide vs Another topical agent or placebo Adverse effects of long‐term use of available topical agents · HIV‐infected adults (> 13 years of age, per CDC) with one or more painful intraoral aphthous ulcers Topical treatments for HIV‐related oral ulcers (2012) · Cochrane | No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6… | 0 studies | No studies |
HAART regimen + topical treatment vs HAART regimen alone Pain relief · HIV‐infected adults (> 13 years of age, per CDC) with one or more painful intraoral aphthous ulcers Topical treatments for HIV‐related oral ulcers (2012) · Cochrane | No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6… | 0 studies | No studies |
HAART regimen + topical treatment vs HAART regimen alone Incidence and recurrence after healing of ulcers · HIV‐infected adults (> 13 years of age, per CDC) with one or more painful intraoral aphthous ulcers Topical treatments for HIV‐related oral ulcers (2012) · Cochrane | No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6… | 0 studies | No studies |
Antiseptic mouthwash (e.g. chlorhexidine) vs Another topical agent or placebo Adverse effects of long‐term use of available topical agents · HIV‐infected adults (> 13 years of age, per CDC) with one or more painful intraoral aphthous ulcers Topical treatments for HIV‐related oral ulcers (2012) · Cochrane | No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6… | 0 studies | No studies |
Topical thalidomide vs Another topical agent or placebo Healing of ulceration · HIV‐infected adults (> 13 years of age, per CDC) with one or more painful intraoral aphthous ulcers Topical treatments for HIV‐related oral ulcers (2012) · Cochrane | No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6… | 0 studies | No studies |
Topical thalidomide vs Another topical agent or placebo Duration to heal oral ulcerations after initiation of treatment · HIV‐infected adults (> 13 years of age, per CDC) with one or more painful intraoral aphthous ulcers Topical treatments for HIV‐related oral ulcers (2012) · Cochrane | No studies were included in this review. A total of 233 abstracts were retrieved; 25 were selected as potentially eligible but all were excluded (10 reported systemic rather than topical treatment; 3 non‐RCTs; 6… | 0 studies | No studies |
Intervention NR Incidence of STI3 ‐ not reported · patients with women living with HIV Behavioral interventions to promote condom use among women living with HIV (2011) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Mortality ‐ not measured · patients with first‐line ART failure Antiretroviral regimens for patients with HIV who fail first‐line antiretroviral therapy (2010) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Disease progression ‐ not measured · patients with first‐line ART failure Antiretroviral regimens for patients with HIV who fail first‐line antiretroviral therapy (2010) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Adherence/tolerability/retention ‐ not reported · patients with first‐line ART failure Antiretroviral regimens for patients with HIV who fail first‐line antiretroviral therapy (2010) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Severity diarrhoea ‐ not reported · patients with HIV exposure (children) Prevention of diarrhoea in children with HIV infection or exposure to maternal HIV infection (2010) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Severe adverse events ‐ not reported · patients with HIV infection or exposure Prevention of diarrhoea in children with HIV infection or exposure to maternal HIV infection (2010) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Anthropometric outcomes ‐ not reported · patients with HIV infection or exposure Prevention of diarrhoea in children with HIV infection or exposure to maternal HIV infection (2010) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Mortality, diarrhoea‐specific ‐ not reported · patients with HIV exposure (children) Prevention of diarrhoea in children with HIV infection or exposure to maternal HIV infection (2010) · Cochrane | no estimate extracted | NR | No studies |